New Tools Unveiled at ASM Annual Meeting Enable Microbiologists to Do More, See More Than Ever Before MENLO PARK, Calif. , June 07, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California Inc. , (Nasdaq:PACB) today announced that obtaining microbial genomes with high accuracy and contiguity has

Gonorrhoea, Deadly Plague and Dysentery Among Collection of Bacterial Genomes Now Publicly Available Through Collaboration with Pacific Biosciences HINXTON, United Kingdom and MENLO PARK, Calif. , June 06, 2018 (GLOBE NEWSWIRE) -- The genomes of more than 3,000 bacteria, including some of the

MENLO PARK, Calif. , May 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore and other parties of patent infringement

MENLO PARK, Calif. , May 02, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced financial results for its first quarter ended March 31, 2018 . Total revenue for the first quarter of 2018 was $19.4 million , compared to $24.9 million for the first quarter

MENLO PARK, Calif. , April 20, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its First Quarter 2018 Financial Results on Wednesday, May 2, 2018 , at 4:30pm Eastern Time .

NIH-funded Program Focuses on Challenging Pediatric Cases; SMRT Sequencing Expected to Increase Solve Rate for Genetic Diagnosis MENLO PARK, Calif. , April 11, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today

MENLO PARK, Calif. , March 27, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced a purchase order for 10 PacBio ® Sequel ® Systems that are expected to be installed at Annoroad’s designated facility

MENLO PARK, Calif. , March 22, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that Judge Leonard P. Stark of the U.S. District Court for the District of Delaware denied a motion to dismiss filed on

Clinical Research Effort Establishes New Quality Control Standards and Reveals Previously Undetected Risks for Gene Therapy Delivery MENLO PARK, Calif. , March 15, 2018 (GLOBE NEWSWIRE) -- A new publication in the journal of the American Society of Gene & Cell Therapy demonstrates the utility of

MENLO PARK, Calif. , March 13, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent No.